Loading...

LYEL LYELL IMMUNOPHARMA INC Management Changes 8-K Filing

LYLL

LYL

LYELL IMMUNOPHARMA INC

(LYEL)

2023 8-K

Show Summary

Show Summary

Merger of Equals

New Clinical Data

Financial Statements

Facility Closure

Financial Results

Acquisition Completed

Clinical Data Release

Board Resignation

Financial Results

Merger Completion

Merger Agreement

Earnings Report

Phase 1 Trial Data Announce...

Earnings Report

Earnings Reports

Repricing of Underwater Opt...

Financial Results Announcement

Investor Presentation

Earnings Report

Annual Meeting of Stockholders

Resignation of Chief Legal ...

Earnings Report

Earnings Reports

External Links:

Lyell Immunopharma, Inc. repriced underwater options held by employees, including top executives, with a new exercise price of $1.87 per share.

AI Assistant

LYELL IMMUNOPHARMA INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.